Liu, X., Liu, W., Ding, C., Zhao, Y., Chen, X., Khatoon, S., . . . Xi, G. (2020). Antidiabetic Effects of Arginyl-Fructosyl-Glucose, a Nonsaponin Fraction from Ginseng Processing in Streptozotocin-Induced Type 2 Diabetic Mice through Regulating the PI3K/AKT/GSK-3β and Bcl-2/Bax Signaling Pathways. Evid Based Complement Alternat Med.
Citação norma ChicagoLiu, Xinglong, Wencong Liu, Chuanbo Ding, Yingchun Zhao, Xueyan Chen, Sadia Khatoon, Yinan Zheng, Zhiqiang Cheng, and Guangsheng Xi. "Antidiabetic Effects of Arginyl-Fructosyl-Glucose, a Nonsaponin Fraction From Ginseng Processing in Streptozotocin-Induced Type 2 Diabetic Mice Through Regulating the PI3K/AKT/GSK-3β and Bcl-2/Bax Signaling Pathways." Evid Based Complement Alternat Med 2020.
Citação norma MLALiu, Xinglong, et al. "Antidiabetic Effects of Arginyl-Fructosyl-Glucose, a Nonsaponin Fraction From Ginseng Processing in Streptozotocin-Induced Type 2 Diabetic Mice Through Regulating the PI3K/AKT/GSK-3β and Bcl-2/Bax Signaling Pathways." Evid Based Complement Alternat Med 2020.